Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Deodhar

Showing results (131-140 of 272) with videos related to

Pageof 28
Sort By:
The Journal of Rheumatology|June 2, 2024
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical TrialsAtul Deodhar, Xenofon Baraliakos, Marina Magrey, et al.
Annals of the Rheumatic Diseases|December 15, 2016
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 studyJürgen Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Arthritis Research & Therapy|December 30, 2016
Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE studyRobert D Inman, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World FindingsVibeke Strand, Atul Deodhar, Rieke Alten, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 1, 2022
Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE StudyAtul Deodhar, Soumya D Chakravarty, Natalie J Shiff, et al.
Arthritis Care & Research|May 28, 2010
Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trialAtul Deodhar, Jürgen Braun, Robert D Inman, et al.
Annals of the Rheumatic Diseases|November 1, 2011
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumabCarrie Wagner, Sudha Visvanathan, Jürgen Braun, et al.
Annals of the Rheumatic Diseases|January 29, 2017
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging studyDésirée van der Heijde, Atul Deodhar, James C Wei, et al.
Rheumatology and Therapy|May 2, 2024
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical DataLars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, et al.
The Journal of Rheumatology|June 17, 2019
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing SpondylitisAtul Deodhar, Dafna D Gladman, Iain B McInnes, et al.
Pageof 28

Showing results (131-140 of 272) with videos related to

Sort By:
Pageof 28
The Journal of Rheumatology|June 2, 2024
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical TrialsAtul Deodhar, Xenofon Baraliakos, Marina Magrey, et al.
Annals of the Rheumatic Diseases|December 15, 2016
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 studyJürgen Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Arthritis Research & Therapy|December 30, 2016
Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE studyRobert D Inman, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World FindingsVibeke Strand, Atul Deodhar, Rieke Alten, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 1, 2022
Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE StudyAtul Deodhar, Soumya D Chakravarty, Natalie J Shiff, et al.
Arthritis Care & Research|May 28, 2010
Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trialAtul Deodhar, Jürgen Braun, Robert D Inman, et al.
Annals of the Rheumatic Diseases|November 1, 2011
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumabCarrie Wagner, Sudha Visvanathan, Jürgen Braun, et al.
Annals of the Rheumatic Diseases|January 29, 2017
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging studyDésirée van der Heijde, Atul Deodhar, James C Wei, et al.
Rheumatology and Therapy|May 2, 2024
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical DataLars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, et al.
The Journal of Rheumatology|June 17, 2019
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing SpondylitisAtul Deodhar, Dafna D Gladman, Iain B McInnes, et al.
Pageof 28